The Equine Veterinary Journal editors have compiled 30 papers from international collaborations for a March 2026 special ...

Scientists have discovered a bacterium in Romanian cave ice that resists antibiotics used to treat infections including tuberculosis, colitis, and UTIs.

Lois Francis, 17, from England, died just seven days after stomach pain. Doctors found a rare parasite infection affecting only 2 in 100,000 people ...

More than 80% of those treated with TREMFYA® were in clinical remission and more than 50% were in endoscopic remission at Week 140 of the QUASAR long-term extension ...

Most bacterial gastrointestinal illnesses in Australia are thought to be caused by two pathogens, Campylobacter and Salmonella. But an emerging pathogen, Aeromonas, is much more common than previously ...

More than 80% of those treated with TREMFYA® were in clinical remission and more than 50% were in endoscopic remission at Week 140 of the QUASAR long-term ...

AltruBio Inc. (“AltruBio” or “the Company”), a clinical stage biotech company developing novel immune checkpoint enhancers to address the unmet need in immunological and inflammatory diseases, with a ...

A novel vaccination approach developed by Vanderbilt Health researchers cleared the harmful gut bacterium Clostridioides difficile (C. diff) in an animal model of infection. An experimental vaccine ...

For most people, talking about poop is uncomfortable, but if you live with ulcerative colitis (UC), a form of inflammatory bowel disease (IBD), it’s unavoidable — and it’s a crucial part of disease ...

Background IBD is a chronic inflammatory condition driven by complex genetic and immune interactions, yet preclinical models often fail to fully recapitulate all aspects of the human disease. A ...

The existing etiological studies of inflammatory bowel disease (IBD) mainly focus on genetics, environment, immunity and gut microbiota (GM). Interestingly, this review found that the first three ...